Xtant Medical Holdings, Inc., a leader in medical technology for spinal, orthopedic, and wound care treatments, has announced the commercial launch of OsteoFactor Pro™, an innovative growth factor solution designed to enhance bone repair. This naturally occurring cocktail of allogeneic growth factors aims to improve bone healing and bolster surgical success in orthopedic and spine procedures. OsteoFactor Pro™ offers a biphasic release profile that stimulates natural bone regeneration pathways, such as targeted angiogenesis, chemotaxis, and osteogenesis. It is a ready-to-use solution that integrates with various scaffolds, providing versatility and superior biologic performance for a wide range of bone regeneration applications. This launch marks Xtant Medical's position as the first vertically integrated company to deliver solutions across all major orthobiologic categories, reflecting its commitment to innovation and comprehensive regenerative medicine.